2011
DOI: 10.1038/eye.2011.189
|View full text |Cite
|
Sign up to set email alerts
|

Hemoglobin AC retinopathy managed with vitrectomy and adjunctive bevacizumab

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 5 publications
(8 reference statements)
0
1
0
Order By: Relevance
“…8 Ten cases of hemoglobin C trait retinopathy have been described; interestingly, most of these reports have all been in individuals with comorbidities such as hypertension. [9][10][11][12][13] The etiology of CRVO in hemoglobin C trait is believed to involve a synergistic mechanism between hemoglobin C and hypertension leading to occlusive microangiopathy. 12 Prior authors have noted cases of peripheral vascular occlusion, vitreous hemorrhage, and retinal neovascularization, but to our knowledge, this is the first report of bilateral CRVO in an individual with hemoglobin C trait.…”
Section: Discussionmentioning
confidence: 99%
“…8 Ten cases of hemoglobin C trait retinopathy have been described; interestingly, most of these reports have all been in individuals with comorbidities such as hypertension. [9][10][11][12][13] The etiology of CRVO in hemoglobin C trait is believed to involve a synergistic mechanism between hemoglobin C and hypertension leading to occlusive microangiopathy. 12 Prior authors have noted cases of peripheral vascular occlusion, vitreous hemorrhage, and retinal neovascularization, but to our knowledge, this is the first report of bilateral CRVO in an individual with hemoglobin C trait.…”
Section: Discussionmentioning
confidence: 99%